Skip to content
GenoLensGenoLens

DHX16

Chr 6p21.33

DEAH-box helicase 16

Aliases:
DBP2, Prp2, PRPF2
MANE:
ENST00000376442.8

Annotations refreshed 9 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Moderate Evidence (Amber)

  • Congenital myopathy

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
  • Early onset or syndromic epilepsy

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • DDG2P

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown

Disease associations (Open Targets)

  • neuromuscular disease and ocular or auditory anomalies with or without seizures

    0.65
  • hereditary disease

    0.42
  • Neurodevelopmental delay

    0.38
  • dengue disease

    0.37
  • neurodevelopmental disorder

    0.37
  • Intellectual disability

    0.35
  • Seizure

    0.32
  • Reduced renal corticomedullary differentiation

    0.26
  • Enlarged kidney

    0.26
  • Multiple renal cysts

    0.26

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16

Required for pre-mRNA splicing as a component of the spliceosome (PubMed:20423332, PubMed:20841358, PubMed:25296192, PubMed:29360106). Contributes to pre-mRNA splicing after spliceosome formation and prior to the first transesterification reaction. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). Also plays a role in innate antiviral response by acting as a pattern recognition receptor sensing splicing signals in viral RNA (PubMed:35263596). Mechanistically, TRIM6 promotes the interaction between unanchored 'Lys-48'-polyubiquitin chains and DHX16, leading to DHX16 interaction with RIGI and ssRNA to amplify RIGI-dependent innate antiviral immune responses (PubMed:35263596)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.